have identified BBI608 (napabucasin), a potent and promise small‐molecule STAT3 inhibitor (US patent 8,877,803), for the first time and found napabucasin could successfully suppress cancer metastasis and relapse in a variety of solid tumors by inhibition of spherogenesis and killing stemness‐high cancer cells. Here, STAT3 is linked to cancer.